These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25178039)

  • 1. Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer.
    Lattanzio R; Ghasemi R; Brancati F; Sorda RL; Tinari N; Perracchio L; Iacobelli S; Mottolese M; Natali PG; Piantelli M
    Oncogenesis; 2014 Sep; 3(9):e118. PubMed ID: 25178039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of Nectin-4 expression in luminal B (HER2 negative) breast cancer.
    Rajc J; Gugić D; Fröhlich I; Marjanović K; Dumenčić B
    Pathol Res Pract; 2017 Sep; 213(9):1102-1108. PubMed ID: 28778498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy.
    Lattanzio R; Marchisio M; La Sorda R; Tinari N; Falasca M; Alberti S; Miscia S; Ercolani C; Di Benedetto A; Perracchio L; Melucci E; Iacobelli S; Mottolese M; Natali PG; Piantelli M;
    Int J Cancer; 2013 Mar; 132(5):1022-31. PubMed ID: 22847294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of Nectin-4 in hepatocellular carcinoma.
    Ma J; Sheng Z; Lv Y; Liu W; Yao Q; Pan T; Xu Z; Zhang C; Xu G
    Onco Targets Ther; 2016; 9():183-90. PubMed ID: 26793002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nectin-1 Expression in Colorectal Cancer: Is There a Group of Patients with High Risk for Early Disease Recurrence?
    Tampakis A; Tampaki EC; Nonni A; Droeser R; Posabella A; Tsourouflis G; Kontzoglou K; Patsouris E; von Flüe M; Kouraklis G
    Oncology; 2019; 96(6):318-325. PubMed ID: 30917374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Potential of Nectin Expressions in Colorectal Cancer: An Exploratory Study.
    Kobecki J; Gajdzis P; Mazur G; Chabowski M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of nectin 3: Novel prognostic marker of lung adenocarcinoma.
    Maniwa Y; Nishio W; Okita Y; Yoshimura M
    Thorac Cancer; 2012 May; 3(2):175-181. PubMed ID: 28920296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Role of Expression of Nectin-4 in Esophageal Cancer.
    Lin X; Hu H; Pan Y; Gao S
    Med Sci Monit; 2019 Dec; 25():10089-10094. PubMed ID: 31883369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT).
    Danish HH; Goyal S; Taunk NK; Wu H; Moran MS; Haffty BG
    Breast J; 2013; 19(3):231-9. PubMed ID: 23528130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer.
    M-Rabet M; Cabaud O; Josselin E; Finetti P; Castellano R; Farina A; Agavnian-Couquiaud E; Saviane G; Collette Y; Viens P; Gonçalves A; Ginestier C; Charafe-Jauffret E; Birnbaum D; Olive D; Bertucci F; Lopez M
    Ann Oncol; 2017 Apr; 28(4):769-776. PubMed ID: 27998973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nectin-4 is a new histological and serological tumor associated marker for breast cancer.
    Fabre-Lafay S; Monville F; Garrido-Urbani S; Berruyer-Pouyet C; Ginestier C; Reymond N; Finetti P; Sauvan R; Adélaïde J; Geneix J; Lecocq E; Popovici C; Dubreuil P; Viens P; Gonçalves A; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Lopez M
    BMC Cancer; 2007 May; 7():73. PubMed ID: 17474988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of Nectin-4 is associated with unfavorable prognosis in gastric cancer.
    Zhang Y; Zhang J; Shen Q; Yin W; Huang H; Liu Y; Ni Q
    Oncol Lett; 2018 Jun; 15(6):8789-8795. PubMed ID: 29805618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.
    Lattanzio R; Iezzi M; Sala G; Tinari N; Falasca M; Alberti S; Buglioni S; Mottolese M; Perracchio L; Natali PG; Piantelli M
    BMC Cancer; 2019 Jul; 19(1):747. PubMed ID: 31362705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience.
    Eralp Y; Kılıç L; Alço G; Başaran G; Doğan M; Dinçol D; Demirci S; İçli F; Onur H; Saip P; Haydaroğlu A
    J Breast Health; 2014 Oct; 10(4):209-215. PubMed ID: 28331673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy.
    Chatterjee S; Sinha S; Kundu CN
    Eur J Pharmacol; 2021 Nov; 911():174516. PubMed ID: 34547246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse.
    Sethy C; Goutam K; Nayak D; Pradhan R; Molla S; Chatterjee S; Rout N; Wyatt MD; Narayan S; Kundu CN
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):245-259. PubMed ID: 31617074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer.
    Zeindler J; Soysal SD; Piscuoglio S; Ng CKY; Mechera R; Isaak A; Weber WP; Muenst S; Kurzeder C
    Front Med (Lausanne); 2019; 6():200. PubMed ID: 31572728
    [No Abstract]   [Full Text] [Related]  

  • 18. Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
    Miao X; Yang ZL; Xiong L; Zou Q; Yuan Y; Li J; Liang L; Chen M; Chen S
    Int J Clin Exp Pathol; 2013; 6(2):179-90. PubMed ID: 23330003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance.
    Klümper N; Ralser DJ; Ellinger J; Roghmann F; Albrecht J; Below E; Alajati A; Sikic D; Breyer J; Bolenz C; Zengerling F; Erben P; Schwamborn K; Wirtz RM; Horn T; Nagy D; Toma M; Kristiansen G; Büttner T; Hahn O; Grünwald V; Darr C; Erne E; Rausch S; Bedke J; Schlack K; Abbas M; Zschäbitz S; Schwab C; Mustea A; Adam P; Manseck A; Wullich B; Ritter M; Hartmann A; Gschwend J; Weichert W; Erlmeier F; Hölzel M; Eckstein M
    Clin Cancer Res; 2023 Apr; 29(8):1496-1505. PubMed ID: 36534531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral expression of CCR3 in breast cancer is associated with improved relapse-free survival in luminal-like disease.
    Gong DH; Fan L; Chen HY; Ding KF; Yu KD
    Oncotarget; 2016 May; 7(19):28570-8. PubMed ID: 27086913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.